April 30, 2019
The Ohio State University College of Pharmacy is pleased to announce that Blake R. Peterson, PhD, has been selected as chair and professor for the college’s Division of Medicinal Chemistry and Pharmacognosy. Peterson, who will join the college in August, is the first in a series of planned faculty recruits focused on cancer drug discovery.
“We are excited and honored to have Dr. Blake Peterson join our faculty. Dr. Peterson’s hire will extend our capabilities in drug discovery and development while further strengthening our partnership with The Ohio State University Comprehensive Cancer Center,” said Henry J. Mann, PharmD, FCCP, FCCM, FASHP, dean and professor at Ohio State’s College of Pharmacy.
The Peterson laboratory creates chemical tools for the study of biological systems, investigates diverse biological targets and employs fluorescence-based and imaging-based methods to evaluate the effects of small molecules, peptides and proteins on isolated proteins, living cells and model organisms. Working in the fields of bioorganic/medicinal chemistry and chemical biology, the lab pursues projects involving anticancer agents, anti-infective agents, molecular probes, tools for target identification and methods for drug delivery. An overarching theme of the group’s work is the identification of new therapeutic approaches, mechanisms and agents.
Peterson is the co-founder of Indigo Biosciences Inc., a leading provider of nuclear receptor and in vitro toxicology solutions that accelerate scientific decision-making.
Peterson received his PhD in chemistry from the University of California and a BS in chemistry from the University of Nevada. He was elected as a fellow of The American Association for the Advancement of Science (AAAS) in 2013 for distinguished contributions to the field of bioorganic chemistry, particularly the development of synthetic mimics of cell surface receptors and fluorescent probes of biological systems. In addition to many other honors, Peterson received the Leading Light Research Award from the University of Kansas in 2012 and was named an Eminent Scholar by the Kansas Biosciences Authority in 2008.